Evidence map›Paper›PMID 24401997›Full record

ArticleThe Journal of investigative dermatology2014

Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif.

Tiffany M Scharadin, Gautam Adhikary, Kristin Shaw, Dan J B Grun, Wen Xu, Richard L Eckert

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. The HRASLS (PLA/AT) subfamily of enzymes.Journal of biomedical science · 2015
    Review
  4. Article
  5. TIG3: an important regulator of keratinocyte proliferation and survival.The Journal of investigative dermatology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tiffany M ScharadinDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Gautam AdhikaryDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kristin ShawDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Dan J B GrunDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wen XuDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Richard L EckertDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA; Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland, USA; Department of Obstetrics and Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA. Electronic address: reckert@umaryland.edu.
University of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Polycomb proteins and skin cancer preventionR01CA131074 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2008 to 2017
$4.6M
KERATINOCYTE DIFFERENTIATION REGULATORR01AR049713 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2004 to 2008
$973k
NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA131074NIAMS NIH HHS R01 AR049713NIAMS NIH HHS R01 AR49713
6 · The paper itself

Abstract

Tazarotene-induced gene 3 (TIG3) is a tumor suppressor protein that has a key role in controlling cell proliferation. TIG3 is observed at reduced levels in epidermal squamous cell carcinoma, and the restoration of expression in skin cancer cells reduces cell survival. TIG3 suppresses cell survival through mechanisms that involve localization at the plasma membrane and at the centrosome. TIG3 interacts at the plasma membrane to activate enzymes involved in keratinocyte terminal differentiation, and at the centrosome to inhibit daughter centrosome separation during mitosis leading to cessation of cell proliferation and induction of apoptosis. An important goal is identifying the motifs required for TIG3 localization at these intracellular sites as a method to understand the function of TIG3 at each location. TIG3 encodes an N-terminal hydrophilic region (amino acids 1-135) and a C-terminal membrane-anchoring domain (amino acids 135-164). We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria. We further demonstrate that a segment of the N-terminal hydrophilic region targets the centrosome. These studies provide important insights regarding the mechanisms that guide subcellular localization of this keratinocyte survival regulator.

Indexed as

ApoptosisCarcinoma, Squamous CellCell Line, TumorCell MembraneCell ProliferationCentrosomeCytoplasmEpidermal CellsEpidermisGenes, Tumor SuppressorGreen Fluorescent ProteinsHumansHydrophobic and Hydrophilic InteractionsKeratinocytesMitochondriaProtein Structure, TertiaryGreen Fluorescent ProteinsPLAAT4 protein, humanReceptors, Retinoic Acid

Identifiers

PMID24401997
PMCPMC3989452
OpenAlexW1982424509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.